Jaguar Health and fitness Promotes Carol Lizak to Chief Economical Officer
4 min readSAN FRANCISCO, CA / ACCESSWIRE / April 6, 2021 / Jaguar Health, Inc. (NASDAQ:JAGX) (“Jaguar” or the “Organization”) introduced these days that the Company has promoted Carol Lizak, an accomplished fiscal government, to the expanded role of main economic officer.
“We are thrilled to have Carol acquire on this essential and expanded purpose as portion of Jaguar’s administration group. Since becoming a member of Jaguar, she has performed a pivotal part in the development and advancement of the Business, demonstrating her know-how in organization and money system,” commented Lisa Conte, Jaguar’s president and CEO. “Carol’s advertising is reflective of her focused leadership and thoughtful contributions throughout finance, accounting, strategic planning, and corporate approach as we have transitioned from an R&D organization to a business-phase entity centered on getting a worldwide leader in the progress and commercialization of novel entries into the industry of gastrointestinal wellbeing. I search forward to continuing to work with Carol as our main monetary officer.”
Ms. Lizak, who joined Jaguar in Could of 2019, formerly held the title of senior vice president of finance and chief accounting officer at the Corporation. She has much more than 20 a long time of company controllership and financial organizing and investigation knowledge underneath U.S. GAAP & IFRS. Prior to joining Jaguar, Ms. Lizak served as senior director and corporate controller of Zosano Pharma Company, as controller of Quantum Protected, Inc., and as government director, corporate controller of Alexza Prescribed drugs, Inc. Prior thereto, she spent 9 many years as company controller of a subsidiary of HID Global Corporation. Ms. Lizak holds an MBA from Pepperdine Graziadio Organization School.
About Jaguar Health and fitness, Inc. and Napo Prescribed drugs, Inc.
Jaguar Wellness, Inc. is a business phase prescription drugs corporation targeted on creating novel, plant-centered, non-opioid, and sustainably derived prescription medicines for men and women and animals with GI distress, exclusively serious, debilitating diarrhea. Our wholly owned subsidiary, Napo Pharmaceuticals, Inc., focuses on developing and commercializing proprietary plant-primarily based human gastrointestinal prescription drugs from crops harvested responsibly from rainforest locations. Our Mytesi® (crofelemer) merchandise is approved by the U.S. Food and drug administration for the symptomatic relief of noninfectious diarrhea in grown ups with HIV/AIDS on antiretroviral therapy and the only oral plant-based prescription medication permitted below Fda Botanical Assistance.
For much more data about Jaguar, be sure to check out https://jaguar.wellness. For more information and facts about Napo, stop by www.napopharma.com.
About Mytesi®
Mytesi® (crofelemer delayed launch tablets) is an antidiarrheal indicated for the symptomatic relief of noninfectious diarrhea in grownup sufferers with HIV/AIDS on antiretroviral therapy (Art). Mytesi® is not indicated for the procedure of infectious diarrhea. Rule out infectious etiologies of diarrhea in advance of starting off Mytesi®. If infectious etiologies are not viewed as, there is a possibility that people with infectious etiologies will not obtain the acceptable treatment and their ailment may possibly worsen. In medical scientific studies, the most popular adverse reactions developing at a price greater than placebo have been upper respiratory tract an infection (5.7{14cc2b5881a050199a960a1a3483042b446231310e72f0dc471a7a1eddd6b0c3}), bronchitis (3.9{14cc2b5881a050199a960a1a3483042b446231310e72f0dc471a7a1eddd6b0c3}), cough (3.5{14cc2b5881a050199a960a1a3483042b446231310e72f0dc471a7a1eddd6b0c3}), flatulence (3.1{14cc2b5881a050199a960a1a3483042b446231310e72f0dc471a7a1eddd6b0c3}), and increased bilirubin (3.1{14cc2b5881a050199a960a1a3483042b446231310e72f0dc471a7a1eddd6b0c3}).
Additional facts and comprehensive Prescribing Details are out there at Mytesi.com. Crofelemer, the energetic component in Mytesi®, is a botanical (plant-primarily based) drug extracted and purified from the red bark sap of the medicinal Croton lechleri tree in the Amazon Rainforest. Napo has recognized a sustainable harvesting system for crofelemer to make sure a substantial degree of quality and ecological integrity.
Forward-Searching Statements
Sure statements in this push launch constitute “ahead-seeking statements.” In some circumstances, you can determine forward-wanting statements by phrases these as “may perhaps,” “will,” “really should,” “hope,” “prepare,” “goal,” “foresee,” “could,” “intend,” “target,” “undertaking,” “ponder,” “imagine,” “estimate,” “predict,” “prospective” or “proceed” or the unfavorable of these terms or other very similar expressions. The ahead-on the lookout statements in this launch are only predictions. Jaguar has centered these forward-hunting statements mainly on its recent expectations and projections about potential situations. These forward-searching statements converse only as of the day of this launch and are subject matter to a amount of pitfalls, uncertainties and assumptions, some of which can’t be predicted or quantified and some of which are outside of Jaguar’s regulate. Other than as necessary by relevant legislation, Jaguar does not plan to publicly update or revise any ahead-hunting statements contained herein, regardless of whether as a final result of any new data, long run functions, modified instances or in any other case.
Contact:
Peter Hodge

Jaguar Health, Inc.
[email protected]

Jaguar-JAGX
Supply: Jaguar Wellbeing, Inc.

View supply variation on accesswire.com:
https://www.accesswire.com/639070/Jaguar-Health-Encourages-Carol-Lizak-to-Main-Financial-Officer
